# Kaituo Biotechnology (Suzhou) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kaituo-biotechnology-suzhou-co

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.catugbio.com
- Latest round: Series A (Apr 25, 2022)
- Investors on record: 6

## About

Based in Suzhou, China and founded in 2021, Kaituo Biotechnology (Suzhou) Co., Ltd. is a pharmaceutical company focusing on the technology development and application of gene therapy and nucleic acid drugs. The company established research and development centers and industrialization bases in Suzhou and Wuhan. The core team comes from Harvard University, University of California, Ohio State University, etc. In December 2022, it awarded Outstanding Enterprise in China Innovation and Entrepreneurship Competition. In June 2024, Kaituo Biotechnology (Suzhou) Co., Ltd. raised strategic investment for approximately CNY 100 million.

The company provides one-stop CDMO services for the entire industry chain of gene cell therapy drugs and nucleic acid drugs from drug research and development, quality research, clinical application and industrialization. It has established three technical service platforms for large-scale plasmid process development and production, mRNA synthesis and delivery full-process process development and production, nucleic acid analysis methods and quality research.

The company generates revenue by providing one-stop CRDMO services for gene cell therapy drugs and nucleic acid drugs.

The company will use the strategic investment to strengthen technology in the field of nucleic acid drugs, expand overseas business, and improve customized services.

## Funding rounds

- Series A, Apr 25, 2022 — NLVC, Oriza Holdings, Genesis Capital, InnoVision Capital, Tsing Song Capital, Lanhu Capital

## Investors

- NLVC (https://capitalatlas.ai/funds/nlvc) — Series A
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A
- Genesis Capital — Series A
- InnoVision Capital (https://capitalatlas.ai/funds/innovision-capital) — Series A
- Tsing Song Capital (https://capitalatlas.ai/funds/tsing-song-capital) — Series A
- Lanhu Capital (https://capitalatlas.ai/funds/lanhu-capital) — Series A